Shademan B, Karamad V, Nourazarian A, Masjedi S, Isazadeh A, Sogutlu F, et al. MicroRNAs as targets for cancer diagnosis: interests and limitations. Adv Pharm Bull. 2023;13:435–45.

Article  PubMed  CAS  Google Scholar 

Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res. 2021;9:18.

Article  PubMed  PubMed Central  Google Scholar 

Pekarsky Y, Balatti V, Croce CM. BCL2 and miR-15/16: from gene discovery to treatment. Cell Death Differ. 2018;25:21–6.

Article  PubMed  CAS  Google Scholar 

Smolarz B, Durczynski A, Romanowicz H, Szyłło K, Hogendorf P. miRNAs in Cancer (Review of Literature). Int J Mol Sci. 2022;23:2805.

Article  PubMed  PubMed Central  Google Scholar 

Wang F, Lou JF, Cao Y, Shi XH, Wang P, Xu J, et al. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. Exp Mol Med. 2015;47:e162.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li W, Wang Y, Liu R, Kasinski AL, Shen H, Slack FJ, et al. MicroRNA-34a: potent tumor suppressor, cancer stem cell inhibitor, and potential anticancer therapeutic. Front Cell Dev Biol 2021;9:640587.

Article  PubMed  Google Scholar 

Ryan KM, Smyth P, Blackshields G, Kranaster L, Sartorius A, Sheils O, et al. Electroconvulsive stimulation in rats induces alterations in the hippocampal miRNome: translational implications for depression. Mol Neurobiol 2023;60:1150–63.

Article  PubMed  CAS  Google Scholar 

Tavakolpour V, Shokri G, Naser Moghadasi A, Mozafari Nahavandi P, Hashemi M, Kouhkan F. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity. J Neuroimmunol. 2018;325:79–86.

Article  PubMed  CAS  Google Scholar 

Chen Z, Chen LY, Dai HY, Wang P, Gao S, Wang K. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. J Cell Biochem. 2012;113:3229–35.

Article  PubMed  CAS  Google Scholar 

Zheng JZ, Huang YN, Yao L, Liu YR, Liu S, Hu X, et al. Elevated miR-301a expression indicates a poor prognosis for breast cancer patients. Sci Rep. 2018;8:2225.

Article  PubMed  PubMed Central  Google Scholar 

Bozgeyik E, Ceylan O. Distinct expression signatures of miR-130a, miR-301a, miR-454 in formalin fixed paraffin embedded tissue samples of prostate cancer patients. Pathol Res Pract. 2022;234:153897

Article  PubMed  CAS  Google Scholar 

Shi YK, Zang QL, Li GX, Huang Y, Wang SZ. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance. J Cancer Res Ther. 2016;2:693–8.

Google Scholar 

Zhang Y, Duan G, Feng S. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun. 2015;459:367–73.

Article  PubMed  CAS  Google Scholar 

Funamizu N, Lacy CR, Kamada M, Yanaga K, Manome Y. MicroRNA-200b and -301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells. Int J Oncol. 2019;3:991–1000.

Google Scholar 

Guo J, Zhong X, Tan Q, Yang S, Liao J, Zhuge J, et al. miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancer. Cell Death Dis 2021;12:696.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asberger J, Berner K, Bicker A, Metz M, Jäger M, Weiß D, et al. In vitro microRNA expression profile alterations under CDK4/6 therapy in breast cancer. Biomedicines 2023;11:2705.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dalmasso B, Hatse S, Brouwers B, Laenen A, Berben L, Kenis C, et al. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy. BMC Cancer 2018;18:1014.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Deng S, Zhang T, Chen X, Shi J, Meng M, Yue G, et al. Is there a correlation between miR-301a expression and neoadjuvant chemotherapy efficacy in breast cancer tissue? Biochem Biophys Rep. 2021;26:100947.

PubMed  PubMed Central  Google Scholar 

Yue X, Lan F, Xia T. Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/β-catenin signaling and promotes radiation resistance by targeting TCEAL7. Mol Ther. 2019;27:1939–49.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang X, Luo G, Zhang K, Cao J, Huang C, Jiang T, et al. Correction: hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis. Cancer Res. 2020;80:922.

Article  PubMed  CAS  Google Scholar 

Karimi N, Ali Hosseinpour Feizi M, Safaralizadeh R, Hashemzadeh S, Baradaran B, Shokouhi B, et al. Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer. J Chin Med Assoc. 2019;82:215–20.

Article  PubMed  Google Scholar 

Lan F, Qing Q, Pan Q, Hu M, Yu H, Yue X. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol. 2018;41:25–33.

Article  CAS  Google Scholar 

Li F, Yoshizawa JM, Kim KM, Kanjanapangka J, Grogan TR, Wang X, et al. Discovery and validation of salivary extracellular RNA biomarkers for noninvasive detection of gastric cancer. Clin Chem. 2018;64:1513–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Santana T, de Oliveira Passamai L, de Miranda FS, Borin TF, Borges GF, Luiz WB, et al. The role of miRNAs in the prognosis of triple-negative breast cancer: a systematic review and meta-analysis. Diagnostics. 2022;13:127.

Article  PubMed  PubMed Central  Google Scholar 

Zhong M, Huang Z, Wang L, Lin Z, Cao Z, Li X, et al. Malignant transformation of human bronchial epithelial cells induced by arsenic through STAT3/miR-301a/SMAD4 loop. Sci Rep. 2018;8:13291.

Article  PubMed  PubMed Central  Google Scholar 

He C, Yu T, Shi Y, Ma C, Yang W, Fang L, et al. MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1. Gastroenterology. 2017;152:1434–48.e15.

Article  PubMed  CAS  Google Scholar 

Guo Y, Xiong Y, Sheng Q, Zhao S, Wattacheril J, Flynn CR. A micro-RNA expression signature for human NAFLD progression. J Gastroenterol. 2016;51:1022–30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Granda-Díaz R, Manterola L, Hermida-Prado F, Rodr¡guez R, Santos L, Garc¡a-de-la-Fuente V, et al. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways. Biomed Pharmacother. 2023;161:114512.

Article  PubMed  Google Scholar 

Li X, Zhong M, Wang J, Wang L, Lin Z, Cao Z, et al. miR-301a promotes lung tumorigenesis by suppressing Runx3. Mol Cancer 2019;18:99.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ni J, Chen Y, Fei B, Zhu Y, Du Y, Liu L, et al. MicroRNA-301a promotes cell proliferation and resistance to apoptosis through PTEN/PI3K/Akt signaling pathway in human ovarian cancer. Gynecol Obstet Invest 2021;86:108–16.

Article  PubMed  CAS  Google Scholar 

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing’s sarcoma cells. Int J Oncol 2016;48:1531–40.

Article